Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

RAPT holding history

RAPT Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPT overviewAll 13F holders of RAPTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RAPT by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−51,324−100.0%Sold outHolders
Q4 202551,324$1.74M<0.1%+29,228+132.3%AddedHolders
Q3 202522,096$569.9K<0.1%+4,082+22.7%AddedHolders
Q2 202518,014$144.1K<0.1%−354,407−95.2%ReducedHolders
Q1 2025372,421$454.4K<0.1%−63,414−14.6%ReducedHolders
Q4 2024435,835$688.6K<0.1%+128,599+41.9%AddedHolders
Q3 2024307,236$617.5K<0.1%−871,659−73.9%ReducedHolders
Q2 20241,178,895$3.60M<0.1%−726,439−38.1%ReducedHolders
Q1 20241,905,334$17.1M<0.1%+859,999+82.3%AddedHolders
Q4 20231,045,335$26.0M<0.1%+283,427+37.2%AddedHolders
Q3 2023761,908$12.7M<0.1%−133,118−14.9%ReducedHolders
Q2 2023895,026$16.7M<0.1%+120,851+15.6%AddedHolders
Q1 2023774,175$14.2M<0.1%+15,990+2.1%AddedHolders
Q4 2022758,185$15.0M<0.1%−14,090−1.8%ReducedHolders
Q3 2022772,275$18.6M<0.1%−271,277−26.0%ReducedHolders
Q2 20221,043,552$19.0M<0.1%−12,405−1.2%ReducedHolders
Q1 20221,055,957$23.2M<0.1%+56,084+5.6%AddedHolders
Q4 2021999,873$36.7M<0.1%+236,129+30.9%AddedHolders
Q3 2021763,744$23.7M<0.1%+417,015+120.3%AddedHolders
Q2 2021346,729$11.0M<0.1%+287,146+481.9%AddedHolders
Q1 202159,583$1.32M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.